Cytek Investor Presentation Deck

Our FSP Platform Allows Us to Address the Broader Cell Analysis Market Agilent BIO RAD Technologies FLUIDIGM BECKMAN $3.0B Cell ID COULTER Miltenyi Biotec BD Marine Biology Thermo Fisher $8B Initial TAM (Cell Analysis Market in 2019 Addressable by Flow Cytometry) SCIENTIFIC $1.9B Cell Proliferation SONY $1.6B Cell Counting & QC $1.0B Single Cell Analysis $2.4B Cell Viability $8B Additional TAM (Cell Analysis Market in 2019 Not Currently Addressable by Flow Cytometry) $23B Long-Term TAM (Total Cell Analysis Market in 2024) Water Supply Contamination $2.4B Cell Signaling $1.3B Cell Interaction Alternative Biofuels $1.3B Target ID CYTEK TRANSCEND THE CONVENTIONAL $1.1B Cell Structure O

View entire presentation